A randomized, placebo-controlled trial of the BTK inhibitor zanubrutinib in hospitalized patients with COVID-19 respiratory distress: immune biomarker and clinical findings
一项针对COVID-19呼吸窘迫住院患者的BTK抑制剂zanubrutinib的随机、安慰剂对照试验:免疫生物标志物和临床结果
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2024.1369619
Treon, Steven P; Kotton, Camille N; Park, David J; Moranzoni, Giorgia; Lemvigh, Camilla K; Gathe, Joseph C Jr; Varughese, Tilly A; Barnett, Christopher F; Belenchia, Johnny M; Clark, Nina M; Farber, Charles M; Abid, Muhammad Bilal; Ahmed, Gulrayz; Patterson, Christopher J; Guerrera, Maria L; Soumerai, Jacob D; Chea, Vipheaviny A; Carulli, Isabel P; Southard, Jackson; Li, Shuqiang; Wu, Catherine J; Livak, Kenneth J; Holmgren, Eric; Kim, Pil; Shi, Carrie; Lin, Holly; Ramakrishnan, Vanitha; Ou, Ying; Olszewski, Scott; Olsen, Lars Rønn; Keskin, Derin B; Hunter, Zachary R; Tankersley, Christopher; Zimmerman, Todd; Dhakal, Binod